Regardless of providers' country or language, they consistently score PowerChart within a five-point range. This is especially noteworthy considering Cerner's global reach.
OREM, UT, October 31, 2013 /24-7PressRelease/
-- Healthcare providers outside of the United States cite functionality and support as the top reasons that Cerner Millennium PowerChart exceeds their expectations notwithstanding high costs and contracting concerns. This information is shared in the latest KLAS report, entitled Cerner Global Performance 2013: A Detailed Look Outside the United States
Furthermore, respondents to the study unanimously report that PowerChart is part of their long-term plans.
"What is interesting about this study is the consistency of the user experience," said Chris Brown, report author. "Regardless of providers' country or language, they consistently score PowerChart within a five-point range. This is especially noteworthy considering Cerner's global reach."
As part of the report, KLAS interviewed providers from 35 organizations outside of the United States. Providers gave feedback on multiple criteria, including functionality, depth of adoption, customer support and value.
For further details, visit KLAS online at www.KLASresearch.com/reports
and view Cerner Global Performance 2013: A Detailed Look Outside the United States
. The report is available to healthcare providers and vendors. Providers receive a significant discount off the standard retail price or can receive a complimentary summary report in exchange for a survey about one of their current vendors.
KLAS is a research firm on a global mission to improve healthcare delivery by enabling providers to be heard and counted. Working with thousands of healthcare professionals and clinicians, KLAS gathers data on software, services, medical equipment and infrastructure systems to deliver timely reports, trends and statistical overviews. The research directly represents the provider voice and acts as a catalyst for improving vendor performance. Follow KLAS on Twitter at www.twitter.com/KLASresearch